First Cases and Risk Factors of Super Yeast Candida Auris Infection or Colonization from Shenyang, China

Overview

Journal Emerg Microbes Infect

Specialty Infectious Diseases

Date 2018 Jul 12

PMID 29992959

Citations 29

Authors

Sufei Tian

Chen Rong

Hua Nian

Fushun Li

Yunzhuo Chu

Shitong Cheng

Hong Shang

Affiliations

Soon will be listed here.

Abstract

For the first time, we identified 15 cases of Candida auris in Shenyang, China, and then performed a risk factor assessment for these patients compared with 30 control subjects who were hospitalized in the same ward during the same period of time as the infected patients. We found that diarrhea, gastrointestinal decompression, infection, or colonization with other Candida isolates (especially Candida albicans) and tetracycline antibiotics were all risk factors for C. auris infection or colonization. Diarrhea and tetracycline antibiotics were independent risk factors. We suggest clinicians pay special attention to the emergence of multidrug-resistant C. auris infections or colonization.

Citing Articles

The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.

Ramos L, Barbosa P, Lorentino C, Lima J, Braga A, Lima R Curr Res Microb Sci. 2025; 8:100354.

PMID: 39995443 PMC: 11847750. DOI: 10.1016/j.crmicr.2025.100354.

Relationships Between and the Rest of the World-Analysis of Dual-Species Biofilms and Infections.

Janeczko M, Skrzypek T Pathogens. 2025; 14(1).

PMID: 39861001 PMC: 11768094. DOI: 10.3390/pathogens14010040.

Evolutionary accumulation of 1 mutations from clinical echinocandin-resistant .

Tian S, Wu Y, Li H, Rong C, Wu N, Chu Y Emerg Microbes Infect. 2024; 13(1):2377584.

PMID: 38989545 PMC: 11265302. DOI: 10.1080/22221751.2024.2377584.

Identifying the risk factors of ICU-acquired fungal infections: clinical evidence from using machine learning.

Zhao Y, Lai Q, Tang H, Luo R, He Z, Huang W Front Med (Lausanne). 2024; 11:1386161.

PMID: 38784232 PMC: 11112035. DOI: 10.3389/fmed.2024.1386161.

-associated hospitalizations and outbreaks, China, 2018-2023.

Bing J, Du H, Guo P, Hu T, Xiao M, Lu S Emerg Microbes Infect. 2024; 13(1):2302843.

PMID: 38238874 PMC: 10802803. DOI: 10.1080/22221751.2024.2302843.

References

Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H . Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009; 53(1):41-4. DOI: 10.1111/j.1348-0421.2008.00083.x. View

Kullberg B, Arendrup M . Invasive Candidiasis. N Engl J Med. 2015; 373(15):1445-56. DOI: 10.1056/NEJMra1315399. View

Perlin D, Rautemaa-Richardson R, Alastruey-Izquierdo A . The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017; 17(12):e383-e392. DOI: 10.1016/S1473-3099(17)30316-X. View

Arauz A, Caceres D, Santiago E, Armstrong P, Arosemena S, Ramos C . Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses. 2017; 61(1):44-47. DOI: 10.1111/myc.12709. View

Schelenz S, Hagen F, Rhodes J, Abdolrasouli A, Chowdhary A, Hall A . First hospital outbreak of the globally emerging in a European hospital. Antimicrob Resist Infect Control. 2016; 5:35. PMC: 5069812. DOI: 10.1186/s13756-016-0132-5. View

Larkin E, Hager C, Chandra J, Mukherjee P, Retuerto M, Salem I . The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrob Agents Chemother. 2017; 61(5). PMC: 5404565. DOI: 10.1128/AAC.02396-16. View

Schiller L, Pardi D, Spiller R, Semrad C, Surawicz C, Giannella R . Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. J Gastroenterol Hepatol. 2013; 29(1):6-25. DOI: 10.1111/jgh.12392. View

Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M . Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012; 50(11):3641-51. PMC: 3486233. DOI: 10.1128/JCM.02248-12. View

Alatoom A, Sartawi M, Lawlor K, AbdelWareth L, Thomsen J, Nusair A . Persistent candidemia despite appropriate fungal therapy: First case of Candida auris from the United Arab Emirates. Int J Infect Dis. 2018; 70:36-37. DOI: 10.1016/j.ijid.2018.02.005. View

10.

Chowdhary A, Sharma C, Duggal S, Agarwal K, Prakash A, Kumar Singh P . New clonal strain of Candida auris, Delhi, India. Emerg Infect Dis. 2013; 19(10):1670-3. PMC: 3810747. DOI: 10.3201/eid1910.130393. View

11.

Al-Siyabi T, Al Busaidi I, Balkhair A, Al-Muharrmi Z, Al-Salti M, Aladawi B . First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases. J Infect. 2017; 75(4):373-376. DOI: 10.1016/j.jinf.2017.05.016. View

12.

Emara M, Ahmad S, Khan Z, Joseph L, Al-Obaid I, Purohit P . Candida auris candidemia in Kuwait, 2014. Emerg Infect Dis. 2015; 21(6):1091-2. PMC: 4451886. DOI: 10.3201/eid2106.150270. View

13.

Calvo B, Melo A, Perozo-Mena A, Hernandez M, Francisco E, Hagen F . First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. J Infect. 2016; 73(4):369-74. DOI: 10.1016/j.jinf.2016.07.008. View

14.

Lee W, Shin J, Uh Y, Kang M, Kim S, Park K . First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011; 49(9):3139-42. PMC: 3165631. DOI: 10.1128/JCM.00319-11. View

15.

Lockhart S, Etienne K, Vallabhaneni S, Farooqi J, Chowdhary A, Govender N . Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses. Clin Infect Dis. 2016; 64(2):134-140. PMC: 5215215. DOI: 10.1093/cid/ciw691. View

16.

Ben-Ami R, Berman J, Novikov A, Bash E, Shachor-Meyouhas Y, Zakin S . Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel. Emerg Infect Dis. 2017; 23(1). PMC: 5324804. DOI: 10.3201/eid2302.161486. View

17.

Welsh R, Bentz M, Shams A, Houston H, Lyons A, Rose L . Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J Clin Microbiol. 2017; 55(10):2996-3005. PMC: 5625385. DOI: 10.1128/JCM.00921-17. View

18.

Vallabhaneni S, Kallen A, Tsay S, Chow N, Welsh R, Kerins J . Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. Am J Transplant. 2016; 17(1):296-299. DOI: 10.1111/ajt.14121. View

19.

Chowdhary A, Sharma C, Meis J . Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. PLoS Pathog. 2017; 13(5):e1006290. PMC: 5436850. DOI: 10.1371/journal.ppat.1006290. View

20.

Magobo R, Corcoran C, Seetharam S, Govender N . Candida auris-associated candidemia, South Africa. Emerg Infect Dis. 2014; 20(7):1250-1. PMC: 4073876. DOI: 10.3201/eid2007.131765. View